Sector
PharmaceuticalsOpen
₹100.9Prev. Close
₹99.72Turnover(Lac.)
₹48.84Day's High
₹101.5Day's Low
₹99.2852 Week's High
₹144.552 Week's Low
₹83Book Value
₹86.33Face Value
₹10Mkt Cap (₹ Cr.)
211.35P/E
10.76EPS
9.35Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 21.04 | 21.04 | 21.04 | 21.04 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 140.93 | 124.07 | 110.6 | 96.48 |
Net Worth | 161.97 | 145.11 | 131.64 | 117.52 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Revenue | 97.55 | 85.96 | 63.38 | 53.5 |
yoy growth (%) | 13.47 | 35.63 | 18.46 | -6.78 |
Raw materials | -59.46 | -50.99 | -36.32 | -27.87 |
As % of sales | 60.95 | 59.31 | 57.3 | 52.1 |
Employee costs | -11.74 | -11.82 | -8.61 | -7.17 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Profit before tax | 10.79 | 5.07 | 11.21 | 10.63 |
Depreciation | -1.22 | -1.14 | -0.76 | -0.83 |
Tax paid | -3.52 | -0.99 | -3.11 | -2.89 |
Working capital | 12.44 | -45.41 | -11.88 | -8.27 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2017 | Mar-2016 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 13.47 | 35.63 | 18.46 | -6.78 |
Op profit growth | 123.3 | -51.39 | 4.2 | 99.33 |
EBIT growth | 106.38 | -59.18 | 7.04 | 8,435.12 |
Net profit growth | 78.13 | -31.91 | -22.6 | -654.09 |
Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|---|
Gross Sales | 112.45 | 108.74 | 92.44 | 112.27 | 97.55 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 112.45 | 108.74 | 92.44 | 112.27 | 97.55 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 23.35 | 14.89 | 9.93 | 10.78 | 4.4 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Exec. Director
Mahendra Singh Chawla
Executive Director
Pravin C Shah
Managing Director
Paresh Chawla
Independent Director
Jyoti Jain
Executive Director
Vitthal Kothana
Independent Director
SUNIL VALECHA
Independent Director
Saket Baheti
Independent Director
Pratibha Lunawat
Whole Time Director
Shitul Shah
Independent Director
Pratik Shah
Company Secretary
Srashti Chopra
33/2 Pigdamber,
A B Road Rau,
Madhya Pradesh - 453446
Tel: 91-731-4294567
Website: http://www.alpalabs.in
Email: [email protected]
Office No 56-2,
Pinnacle Busine.Park, Mahakali Caves Road,
Mumbai - 400093
Tel: 91-22-62638200
Website: www.bigshareonline.com
Email: [email protected]
Summary
M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In...
Read More
Reports by Alpa Laboratories Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.